nTMS for Brain Metastasis Planning
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial studies how well nTMS works in planning radiation therapy for patients with brain metastases in the motor cortex. nTMS maps brain areas that control muscles, helping doctors avoid damaging these critical areas during treatment. This could lead to safer and more effective radiation therapy. nTMS has been widely used for planning in brain tumor surgeries to map important areas and improve patient outcomes.
Who Is on the Research Team?
Caroline Chung
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
This trial is for adults with brain metastases in the motor cortex who've had stereotactic radiosurgery (SRS) 3-18 months prior. Participants must be able to undergo nTMS and EMG, have used MRI for SRS planning, and complete questionnaires in English. Excluded are those with significant cognitive/psychiatric issues or poor physical status that prevents participation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Diagnostic
Patients undergo nTMS and perform tasks testing grip and pinch strength
Follow-up
Participants are monitored for safety and effectiveness after diagnostic procedures
What Are the Treatments Tested in This Trial?
Interventions
- Navigated Transcranial Magnetic Stimulation
- Stereotactic Radiosurgery
Stereotactic Radiosurgery is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator